A groundbreaking study introduces new noninvasive screening tools that have the potential to greatly enhance patient comfort and clinical outcomes. Researchers have found that examining certain patterns of cell-free DNA (cfDNA) fragments in urine can accurately identify and assess the stage of bladder cancer. This method provides a promising alternative to invasive procedures like cystoscopies. […]
Source link